**诺和诺德基金会与英伟达联手，在丹麦打造AI超级计算机Gefion用于新药和疗法发现**
据科创板日报报道，诺和诺德基金会于当地时间3月18日宣布，将与全球知名图形处理器制造商英伟达合作，在丹麦建造一台名为Gefion的AI超级计算机。此次合作旨在利用英伟达先进的AI技术，加速新药和疗法的发现进程，以应对全球日益严峻的疾病治疗挑战。
据悉，Gefion超级计算机将运行英伟达的AI技术，其强大的计算能力将为药物和疗法的研究提供有力支持。诺和诺德基金会表示，Gefion将可供丹麦公共和私营部门的研究人员使用，以推动该国药物研发领域的发展。
此次合作体现了诺和诺德基金会对科技创新的重视。近年来，随着AI技术的迅猛发展，其在药物研发领域的应用逐渐受到关注。通过利用AI的计算能力和大数据分析，研究人员可以更快地筛选出有潜力的新药候选物，从而提高药物研发的效率和成功率。
诺和诺德基金会与英伟达的合作，是AI技术在药物研发领域的一次重要突破。Gefion超级计算机的建成将为全球药物研发工作者提供强大的计算支持，助力新药和疗法的发现。此次合作也展示了丹麦在全球科技创新领域的积极姿态，有望为全球疾病治疗带来新的希望。
作为一家拥有丰富新闻报道经验的记者，我深感此次合作的重大意义。相信在不久的将来，Gefion超级计算机将助力科研人员取得更多突破性成果，为人类健康事业作出更大贡献。
英语如下：
**Headline:** “Novo Nordisk Foundation Teams Up With NVIDIA to Build AI Supercomputer Gefion in Denmark for Drug Discovery”
Keywords: Novo Nordisk Foundation, AI Supercomputer, Drug Discovery.
**News Content:**
**Novo Nordisk Foundation and NVIDIA Partner to Develop AI Supercomputer Gefion in Denmark for New Drug and Therapy Discovery**
According to the Science and Technology Daily, the Novo Nordisk Foundation announced on March 18 that it will partner with NVIDIA, a globally renowned manufacturer of graphics processing units (GPUs), to build an AI supercomputer named Gefion in Denmark. The collaboration aims to harness NVIDIA’s advanced AI technology to expedite the discovery of new drugs and therapies, addressing the increasingly challenging global landscape of disease treatment.
It is understood that Gefion will run NVIDIA’s AI technology, providing robust computational power to support research in drugs and therapies. The Novo Nordisk Foundation stated that Gefion will be available for researchers from both public and private sectors in Denmark, to drive the country’s development in pharmaceutical research.
This collaboration reflects the Novo Nordisk Foundation’s emphasis on technological innovation. In recent years, as AI technology has rapidly advanced, its application in the field of drug development has garnered increasing attention. By utilizing AI’s computational capabilities and big data analytics, researchers can more rapidly identify potential new drug candidates, thereby enhancing the efficiency and success rate of drug development.
The partnership between the Novo Nordisk Foundation and NVIDIA represents a significant breakthrough in the application of AI technology in drug development. The completion of Gefion supercomputer will provide substantial computational support to global drug researchers, aiding in the discovery of new drugs and therapies. This collaboration also demonstrates Denmark’s proactive stance in the global field of technological innovation, offering new hope for global disease treatment.
As a journalist with extensive reporting experience, I deeply appreciate the significant implications of this collaboration. I believe that in the near future, Gefion supercomputer will empower researchers to achieve more breakthroughs, contributing significantly to the health of humanity.
【来源】https://www.chinastarmarket.cn/detail/1624366
Views: 6